Adult

Temocillin

Warning

General Information

A penicillin antibiotic. Do NOT use if patient is allergic to penicillin.

Restricted formulary antimicrobial: For details see OUH netFormulary

AWaRe antibiotic classification: 'Watch'. Use as per guidelines. 

Standard dose

2g IV BD

For bacteraemia with susceptible organism or in critically unwell patients: the dose can be increased to 2g IV TDS.

 

Obesity

Dosing for penicillins should be at the upper end of recommended ranges, particularly for morbidly obese patient with severe infections, considering patient’s renal function.

Renal and hepatic impairment

Renal impairment

Note: Accumulation of sodium from injection can occur in patients with renal failure.

Creatinine clearance (mL/min)

Where the usual dose would be

2g BD temocillin

Where the usual dose would be

2g TDS temocillin

More than 60

No adjustment

No adjustment

40-60

No adjustment

2g BD

20-40

2g STAT then 1g BD

less than 20

 2g STAT then 1g OD

Note: dose ranges use creatinine clearance, rather than eGFR.

 

Hepatic impairment

No dose adjustment required in hepatic impairment.

Notable Interactions

Methotrexate: Temocillin can reduce excretion of methotrexate (increased risk of toxicity).

Vitamin K antagonists: Appropriate monitoring should be undertaken. It would be prudent to monitor coagulation status within 3 days of starting or stopping a penicillin.

This is not a complete list. Please see the BNF, Summary of Product Characteristics or speak to a pharmacist.

Pregnancy and breastfeeding

Pregnancy

Discuss with pharmacy

Breastfeeding

Caution. Discuss with pharmacy. Very little published evidence: trace amounts in milk.

Additional information

  • 2g of temocillin contains approximately 10mmol of sodium. Accumulation of sodium from injection can occur with high doses and in patients with renal failure.
  • Monitor potassium. Risk of hypokalaemia in patients with low potassium reserves and those who are receiving cytotoxic therapy or diuretics.

References

Editorial Information

Next review date: 04 Jan 2027